- Home
- PRTA vs ITRG Comparison
PRTA vs ITRG Comparison
Compare PRTA & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRTA | ITRG |
|---|---|---|
| Founded | 2012 | 1997 |
| Country | Ireland | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 495.8M | 482.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PRTA | ITRG |
|---|---|---|
| Price | $9.12 | $3.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $18.86 | $4.13 |
| AVG Volume (30 Days) | 729.9K | ★ 1.9M |
| Earning Date | 02-19-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | $11,786,000.00 | ★ $219,125,000.00 |
| Revenue This Year | N/A | $965.93 |
| Revenue Next Year | $819.08 | $9.39 |
| P/E Ratio | ★ N/A | $54.65 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.32 | $0.79 |
| 52 Week High | $16.67 | $4.69 |
Technical Indicators
Market Signals| Indicator | PRTA | ITRG |
|---|---|---|
| Relative Strength Index (RSI) | 40.87 | 49.24 |
| Support Level | $8.95 | $3.73 |
| Resistance Level | $9.47 | $4.10 |
| Average True Range (ATR) | 0.37 | 0.23 |
| MACD | -0.03 | -0.08 |
| Stochastic Oscillator | 22.61 | 20.50 |
Price Performance
Historical ComparisonAbout PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.